Low-dose Interleukin-2 and Pembrolizumab in Melanoma and Renal Cell Cancer
Clinical trial NCT03111901 · WITHDRAWN
Trial details
- NCT number
- NCT03111901
- Sponsor
- William Grosh, MD
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-29
- Primary completion
- 2023-10-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.